Emcure launched first generic version of Eisai Pharmaceutical’s Halaven (Eribulin) in India
Emcure Pharmaceuticals announced the launch of first generic version of Eisai Pharmaceutical’s Halaven (Eribulin) for the treatment of metastatic breast cancer (MBC).... Read More